Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras(National Institutes of Health), Barton F. Haynes(Duke University)
Cited by 624
Related Papers
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
|The Lancet|2018|342
Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies
|Science|2015|202
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
|The Journal of Infectious Diseases|2011|177